Rankings
▼
Calendar
BSX Q1 2021 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$105B
Q1 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$2.8B
+8.2% YoY
Gross Profit
$1.7B
60.6% margin
Operating Income
$360M
13.1% margin
Net Income
$341M
12.4% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
+1.6%
Cash Flow
Operating Cash Flow
$284M
Free Cash Flow
$209M
Stock-Based Comp.
$47M
Balance Sheet
Total Assets
$30.9B
Total Liabilities
$15.2B
Stockholders' Equity
$15.7B
Cash & Equivalents
$2.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.8B
$2.5B
+8.2%
Gross Profit
$1.7B
$1.5B
+10.2%
Operating Income
$360M
$223M
+61.4%
Net Income
$341M
$11M
+3000.0%
Revenue Segments
Cardiovascular
$1.1B
41%
MedSurg
$860M
31%
Cardiac Rhythm Management
$750M
27%
Geographic Segments
UNITED STATES
$1.6B
58%
Non-US
$1.2B
42%
← FY 2021
All Quarters
Q2 2021 →